These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16750479)

  • 1. Complex-1 activity and 18F-DOPA uptake in genetically engineered mouse model of Parkinson's disease and the neuroprotective role of coenzyme Q10.
    Sharma SK; El Refaey H; Ebadi M
    Brain Res Bull; 2006 Jun; 70(1):22-32. PubMed ID: 16750479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metallothionein-mediated neuroprotection in genetically engineered mouse models of Parkinson's disease.
    Ebadi M; Brown-Borg H; El Refaey H; Singh BB; Garrett S; Shavali S; Sharma SK
    Brain Res Mol Brain Res; 2005 Mar; 134(1):67-75. PubMed ID: 15790531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism.
    Abdin AA; Hamouda HE
    Neuropharmacology; 2008 Dec; 55(8):1340-6. PubMed ID: 18817789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution kinetics of 18F-DOPA in weaver mutant mice.
    Sharma SK; Ebadi M
    Brain Res Mol Brain Res; 2005 Sep; 139(1):23-30. PubMed ID: 15979197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coenzyme Q10 inhibits mitochondrial complex-1 down-regulation and nuclear factor-kappa B activation.
    Ebadi M; Sharma SK; Wanpen S; Amornpan A
    J Cell Mol Med; 2004; 8(2):213-22. PubMed ID: 15256069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metallothionein attenuates 3-morpholinosydnonimine (SIN-1)-induced oxidative stress in dopaminergic neurons.
    Sharma SK; Ebadi M
    Antioxid Redox Signal; 2003 Jun; 5(3):251-64. PubMed ID: 12880480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects.
    Matthews RT; Yang L; Browne S; Baik M; Beal MF
    Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8892-7. PubMed ID: 9671775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metallothioneins 1 and 2 attenuate peroxynitrite-induced oxidative stress in Parkinson disease.
    Ebadi M; Sharma S
    Exp Biol Med (Maywood); 2006 Oct; 231(9):1576-83. PubMed ID: 17018883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases.
    Yang L; Calingasan NY; Wille EJ; Cormier K; Smith K; Ferrante RJ; Beal MF
    J Neurochem; 2009 Jun; 109(5):1427-39. PubMed ID: 19476553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective actions of coenzyme Q10 in Parkinson's disease.
    Sharma S; Kheradpezhou M; Shavali S; El Refaey H; Eken J; Hagen C; Ebadi M
    Methods Enzymol; 2004; 382():488-509. PubMed ID: 15047119
    [No Abstract]   [Full Text] [Related]  

  • 11. Coenzyme Q(10) provides neuroprotection in iron-induced apoptosis in dopaminergic neurons.
    Kooncumchoo P; Sharma S; Porter J; Govitrapong P; Ebadi M
    J Mol Neurosci; 2006; 28(2):125-41. PubMed ID: 16679553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment.
    Beal MF
    J Bioenerg Biomembr; 2004 Aug; 36(4):381-6. PubMed ID: 15377876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WITHDRAWN: Coenzyme Q10 for Parkinson's disease.
    Liu J; Wang LN; Zhan SY; Xia Y
    Cochrane Database Syst Rev; 2012 May; 2012(5):CD008150. PubMed ID: 22592726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrastriatal administration of coenzyme Q10 enhances neuroprotection in a Parkinson's disease rat model.
    Park HW; Park CG; Park M; Lee SH; Park HR; Lim J; Paek SH; Choy YB
    Sci Rep; 2020 Jun; 10(1):9572. PubMed ID: 32533070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dopaminergic neurotoxin MPTP/MPP+ on coenzyme Q content.
    Dhanasekaran M; Karuppagounder SS; Uthayathas S; Wold LE; Parameshwaran K; Jayachandra Babu R; Suppiramaniam V; Brown-Borg H
    Life Sci; 2008 Jul; 83(3-4):92-5. PubMed ID: 18565546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of cocaine and methamphetamine neurotoxicity by coenzyme Q10.
    Klongpanichapak S; Govitrapong P; Sharma SK; Ebadi M
    Neurochem Res; 2006 Mar; 31(3):303-11. PubMed ID: 16733807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coenzyme Q10 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseases.
    Beal MF; Matthews RT
    Mol Aspects Med; 1997; 18 Suppl():S169-79. PubMed ID: 9266519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of mitochondria in neuronal cell death induced by oxidative stress; neuroprotection by Coenzyme Q10.
    Somayajulu M; McCarthy S; Hung M; Sikorska M; Borowy-Borowski H; Pandey S
    Neurobiol Dis; 2005 Apr; 18(3):618-27. PubMed ID: 15755687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxynitrite in the pathogenesis of Parkinson's disease and the neuroprotective role of metallothioneins.
    Ebadi M; Sharma SK; Ghafourifar P; Brown-Borg H; El Refaey H
    Methods Enzymol; 2005; 396():276-98. PubMed ID: 16291239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease.
    Shults CW; Flint Beal M; Song D; Fontaine D
    Exp Neurol; 2004 Aug; 188(2):491-4. PubMed ID: 15246848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.